Affimed(AFMD)

6.90 0.27 4.0724%

今开:6.71昨收:6.63
最高:7.03 最低:6.62
涨停价:0.0跌停价:0.0
总市值:8.20776252E8

Affimed的热门评论

Affimed(AFMD)2019-02-13 08:30

$Affimed(AFMD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0000902219-19-000079 Size: 37 KB 网页链接查看全文

Pharmayang2018-03-07 13:56

$Affimed N.V. (AFMD)$ 今天完成了hodgkin lymphomas 病人的recruit,但delay了CD19 completion 时间。这个公司执行力不是很好,经常delay。不过双特异性抗体的药效不错,现在股价窄幅震荡,在等non hodgkin lymphoma的低dose结果出来,估计还要2,3个月,或者其他合作的机会。耐心等待,希望到6月...查看全文

Affimed(AFMD)2019-01-26 08:30

$Affimed(AFMD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-25 AccNo: 0000950103-19-000893 Size: 44 KB 网页链接查看全文

Pharmayang2018-02-05 22:58

$Affimed N.V. (AFMD)$ 治疗hodgkin lymphoma的数据非常好,8/9的response rate,而且绝大多数病人是fail了其他的治疗手段。现在的估值依然诱人,可以买。查看全文

Affimed(AFMD)2019-01-16 08:30

$Affimed(AFMD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-15 AccNo: 0001319244-19-000005 Size: 157 KB 网页链接查看全文

美股医药Z博士2017-12-04 22:20

$Affimed N.V.(AFMD)$ 简而言之,ASH大会公布主要药物AFM13与Keytruda联用在霍奇金淋巴瘤的Ib实验,看好实验数据,建议大会前买一波行情。查看全文

大__跌2018-10-25 01:47

我说是出货形态吧$Affimed N.V. (AFMD)$//@跌_跌_跌_跌:回复@Fran恪:只说技术分析啊,这明显是个拉高出货的形态,怎么会大涨呢?$Affimed N.V. (AFMD)$查看全文

绿豆哇112018-10-09 04:35

$Affimed N.V. (AFMD)$ 停盘了。。要被血洗了?[吐血]查看全文

神是怎样炼成的2018-09-29 08:32

$Affimed N.V. (AFMD)$ 4.3就是底了吧,真要是吃到大阳线底部搞不好会补缺口[哭泣]查看全文

无为无谓无畏2018-09-26 00:59

$Affimed N.V. (AFMD)$ 今天盘前暴涨,开盘暴跌,一个小时后又迅速拉起,看样子是有主力进场了查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35

Affimed的公告

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-205507 Act: 34 Size: 392 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-192099 Act: 34 Size: 29 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-167904 Act: 34 Size: 131 KB 网页链接

$Affimed(AFMD)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-21-000373 Act: 34 Size: 107 KB 网页链接

$Affimed(AFMD)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-21-053202 Act: 34 Size: 77 KB 网页链接

$Affimed(AFMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001047469-21-000956 Act: 34 Size: 8 MB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-117084 Act: 34 Size: 170 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-116238 Act: 34 Size: 2 MB 网页链接

$Affimed(AFMD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-050088 Act: 34 Size: 94 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-110851 Act: 34 Size: 42 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21